Pharma Sector - Understanding Entire Value Chain
Vložit
- čas přidán 28. 06. 2024
- In this comprehensive video, we delve into the intricate details of the entire value chain of the Pharma sector. From research and development to production, marketing, and distribution, we explore every stage in the process of bringing pharmaceutical products to the market. Gain a deep understanding of the complex network involved in the Pharma industry as we dissect the supply chain, regulatory environment, and various stakeholders' roles. Whether you are an industry professional, investor, or simply curious about the workings of this vital sector, this video provides invaluable insights
00:00 Introduction
01:15 Global Pharma Market (USD B)
03:57 Global Pharma Market - Innovators vs Generic (US$ billion)
06:38 PHARMA VALUE CHAIN
09:19 R&D
14:40 Estimated Market Spending vs Outsourced Spend 2017
17:56 R&D Outsourcing From India
25:41 ANDA approvals from US FDA
27:27 R&D as a % of Sales
28:13 Manufacturing
33:10 CDMO, CRO & CRAMS
35:18 CRAMS INDUSTRY
37:20 Indian Player in CRAMS Industry
40:36 Overview of API industry in India
44:16 Indian Players’ US Business
45:44 Indian Branded
46:55 Indian Pharma Value Chain (%MRP Build up)
47:37 IPM-Acute vs Chronic
48:46 IPM by Therapy
50:50 Key Players in the OTC market in India
53:14 IPM - Average NLEM contribution in IPM sales
53:57 Biggest Pharma
Complete Fundamental Stock Analysis Tool - Stock-o-meter:
investyadnya.in/stock-o-meter
Research Based Ready-made Model Portfolios:
investyadnya.in/model-portfolios
Comprehensive Mutual Fund Reviews:
investyadnya.in/fund-o-meter
Yadnya Books and eBooks now available:
On Amazon - amzn.to/2XKtlks
On our website - investyadnya.in/books
Find us on Social Media and stay connected:
Blog - blog.investyadnya.in
Telegram - t.me/InvestYadnya
Facebook Page - / investyadnya
Facebook Group - goo.gl/y57Qcr
Twitter - / investyadnya
LinkedIn - / investyadnya
#PharmaSectorExplained #ValueChainInPharma #PharmaceuticalProducts #IndustryInsights #PharmaMarketTrends #ExplorePharmaIndustry #PharmaceuticalSupplyChain #RegulatoryEnvironment
LEGAL DISCLAIMER:
Use of this information is at the user's own risk. The Company and its directors, associates and employees will not be liable for any loss or liability incurred to the user due to investments made or decisions taken based on the information provided herein. The investment discussed or views expressed herein may not be suitable for all investors. The users should rely on their own research and analysis and should consult their investment advisors to determine the merit, risks and suitability of recommendation. Past performance is not a guarantee for future performance or future results. Information herein is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The images used may be copyright of the company or third party. As a condition to using the services, the user agrees to the terms of use of the website and the services.
DISCLOSURES UNDER SEBI (RESEARCH ANALYST) REGULATIONS, 2014:
Yadnya Academy Pvt. Ltd. (InvestYadnya) is registered with SEBI under SEBI (Research Analyst) Regulations, 2014 with registration no. INH000008349.
Disclosure with regard to ownership and material conflicts of interest
1. Neither Research Analyst nor the entity nor his associates or relatives have any financial interest in the subject Company;
2. Neither Research Analyst nor the entity nor its associates or relatives have actual / beneficial ownership of one per cent or more securities of the subject Company, at the end of the month immediately preceding the date of publication of the research report or date of public appearance;
3. Neither Research Analyst nor the entity nor its associates or his relatives have any other material conflict of interest at the time of publication of the research report or at the time of public appearance.
Disclosure with regard to receipt of Compensation
1. The Research Entity and its associates have not received compensation from the subject company in the past twelve months.
2. The subject company is not or was not a client during the twelve months preceding the date of recommendation.
Most underrated channel in youtube for finance aspirants
As a final year B Pharm student I would say spending 55 minutes is worth it. Amazing analysis. Thank you
Your look and your analytical brain game both are simply out of the world collection. I learned a lot, a lot - from you.
Thank you sir- one of the best value adding series of CZcams
It seems like you are Pharma domain expert. Very well explained.
Sir, we need banking and hotel industry knowledge as same like this video
Great video.Till now I have watched this video 5 times in two days. Finally noted every important thing. It was really a much needed video for me as I got very much perplexed whenever I read about any Pharma company. Keep doing such good work sir.
Thank u sir. Clearly explained. I didnt know how pharm sector work. Now i knew clear explanation.
Every minute of the video was worth watching.
Excellent analysis and presentation in lucid language. Thank you so much 🙏
Thanks for giving us amazing knowledge about Pharma sector
Realy admire your value chain series
Excellent video Sir! I am being pharma professional, corelate well.❤
Excellent job, thank you and kudos for your efforts❤
Thank You Sir, Great Video It real Helped a lot to Undertand Pharma Sector.Every one Must watch it befor investing in Pharma sector.
Thank you sir for such amazing information..😊
explained in great detail with all the data and sources
Your value chain videos are very helpful. Thankyou for making these types of videos for us.❤
Thank you gaurav sir
Best explanation !
Excellent video . Cleared concept
Very well explained for a layma. Especially the terms used in the pharma industry.
Excellent analysis
Excellent research sir
Thanks a lot
Great Pharma teacher
Thank you
Thank you sir 🙏
Good evening sir.. I love your analysis very much..
THANK YOU SO MUCH SIR
Very effective transaction of information on Pharma sector. It is useful to me to select Pharma companies for investment purpose
Wonderful Analysis
Awesome video..
I appreciate the effort that you people have put in to provide this quality content.
I am sure that this kind of summarised content is not available in youtube.
Its very sad to see that people give millions of views to the videos with title `How I made 1 crore with trading?` and not watching this kind of valuable videos.
There kind of videos can be good starting point for the people what wants to learn more about particular sector.
Absolutely right
Very true !
Sir, there is mis-information regarding form 483
Form of 483 is issued after every inspection by US FDA. USFDA specifies its list of observations in form 483. Company submits capa plan answering their response to the USFDA,observations
If the regulator is satisfied, it issues NAI certificate
if the regulator is satisfied but want to further reinspect it issues VAI
If the regulator is not satisfied, it issues OAI status
Even after OAI status, medicines can be exported to the US market but if regulator is not satisfied, it issues, warning letter and import alert Signifying ban of drug import from that plant into USA
Thanks 🙏
Very informative video. ...A matured channel.
very informative. Bahut badiya
Very good analysis, with facts and figures presented very effectively.....Thank You
Awesome discussion 👏 👌 👍
Great video, thanks for making it.
Excellent presentation
Great effort
Wow.. this was really well researched and explained in easy terms( considering the complexity of the sector). I only wish some time could have been spent on the chemical ingredients and their manufacturers.
Fantastic - very good coverage in all ways
Great Video. Indepth analysis. Keep it up.
Great effort 💯 👍🎉
Sir very useful information.
What a informative video❤
Gaurav Brilliant 👏 👌
Very insightful and useful video sir, please keep uploading such high quality content
Zydus life is also big into R&D
It is itself doing Pharma 3 clinical trial for its NDA Drug Saroglitizar
This drug is approved in India by Indian drug regulators and is among top 10 selling drug brand in india with fast growth and adoption among patients
Very good video have ever seen.
Subah subah uthke dekha
Felt good
Sir it is really really helpful to understand the Pharma sector in and out.
Sir, will it be possible to go deeper into R&D and Manufacturing separately.... doesn't matter how long the videos are ....as long as you are delivering your insights - it seems that time has glided by rather too soon
Expected a reply from you Sir
So much interesting more then movie, wow
Thank you for enhancing our knowledge ❤
😊😊
Wonderful session sir
It was very informative.
Sir thanks
There is also patent term extension for 5 years after patent expires.
Also, exclusivity depends on the drug. whether it is a rare disease drug or normal drug.
I am also pharmacist. Apka pharma value chain ya pharma business ka knowledge acha hai..
Very good
Sir kindly make a playlist of value chain analysis
Sir please we need more videos on pharma marketing❤
Gained from ur presentation 👍🏼
Give it name master class
Excellent explanation, one small request sir plz provide ppt
👌
Please refer the best company to buy now
Please give information information about USA Pharma company 🙏
One of the best video ever. So nicely explained and in simple words at good pace.... Amazing, please keep creating such videos.
Request you to make such videos on speciality chemicals
What valuation multiple should be ideal for domestic as well as global pharma indian co
Have api earning capitalised more in the past barring covid-19 than formulation the earnings for incremental revenue growth and profitability?
Sir please do IT sector analysis
very nice video...use markers in ppt
What is api and formulation in common man terms pls. What is the difference?
Ipca, cipla, sun, aurobindo, divis lab , alkem
Company wise revenue of chronic medicines business??
Sir can you please clear my doubt about which pharma company is biggest - I taght its Dr Reddy but you said its sun pharma , can you plz explain it further is on the basis on Inidan market or On basis on B2B or B2C basis?
Sir gland pharma ka naam nhi h kya?
Next value chain konsi karenge???
Would be great if you could do the video in English
Where is Divis Lab
Chemical Sector please
Thank you sir. Sir mae b pharm from maharishi arvind institute of pharmacy
Paracetamol is a pain killer. Not antiinfective
Jo chal rahaa hai vo sab batate hain, magar aisaa sector lavo jo future mein chalne wala ho, starting mein invest karein to madad milegaa. Please
Jab se news aaya pharma negative return?
Thank you
Excellent research sir
Thanks a lot